Skip to main content
. 2010 Oct 21;15(10):7378–7394. doi: 10.3390/molecules15107378

Table 2.

Cytotoxicity (IC50 values, µM) of the compounds 1-5, 7-16, 18-20.

Compound Cytotoxicitya IC50 (µM)b
MRC-5 AGS Hep G2
1 447 ± 26 189 ± 9 242 ± 13
2 > 1,000 > 1,000 > 1,000
3 > 1,000 445 ± 27 806 ± 32
4 288 ± 11 167 ± 7 321 ± 14
5 260 ± 15 149 ± 7 291 ± 11
7 459 ± 32 266 ± 16 364 ± 15
8 890 ± 45 592 ± 30 841 ± 42
9 119 ± 7 82 ± 4 67 ± 3
10 > 1,000 > 1,000 > 1,000
11 > 1,000 361 ± 18 541 ± 22
12 380 ± 19 309 ± 18 673 ± 34
13 449 ± 29 308 ± 17 808 ± 48
14 > 1,000 297 ± 14 894 ± 56
15 > 1,000 > 1,000 > 1,000
16 > 1,000 483 ± 29 529 ± 36
18 495 ± 35 > 1000 > 1000
19 267 ± 14 206 ± 10 316 ± 16
20 > 1,000 > 1,000 > 1,000
Lansoprazole 306 ± 11 162 ± 6 221 ± 9

a Cultured human cell lines: MRC-5, human normal lung fibroblasts; AGS, gastric epithelial adenocarcinoma cells; Hep G2, hepatocytes. b Values are arithmetic means of three different experiments in quadruplicate ± SD. Confluent cultures were treated with the culture medium containing the compounds at concentrations ranging between 0 and 1000 µM for 24 h. Cell viability was determined by the neutral red uptake assay. c Lansoprazole was used as the reference drug.